Improved survival with an intact DNA mismatch repair system in endometrial cancer

Obstetrics and Gynecology

Volumn 108, Issue 5, 2006, Pages 1208-1215

  Cohn, David E ^a,b   Frankel, Wendy L ^a   Resnick, Kimberly E ^a   Zanagnolo, Vanna L ^a   Copeland, Larry J ^a   Hampel, Heather ^a   Kelbick, Nicole ^a   Morrison, Carl D ^a   Fowler, Jeffrey M ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b M 210 Starling Loving Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH3; PROTEIN MSH6;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MISMATCH REPAIR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; TISSUE MICROARRAY;

ADENOSINE TRIPHOSPHATASES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARRIER PROTEINS; DISEASE-FREE SURVIVAL; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS;

EID: 33750515665     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000239097.42987.0c     Document Type: Article

References (23)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer Statistics, 2006. CA Cancer J Clin 2006;56:106-30
2. Kowalski LD, Mutch DG, Herzog TJ, Rader JS, Goodfellow PJ. Mutational analysis of MLH1 and MSH2 in 25 prospectively-acquired RER+ endometrial cancers. Genes Chromosomes Cancer 1997;18:219-27.
3. Aarnio M, Sankila R, Pukkala E, Salovaar R, Aaltonen LA, Peltomaki P, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999;81:214-8.
4. Risinger JI, Berchuck A, Kohler MF, Watson P, Lynch HT, Boyd J, et al. Genetic instability of microsatellites in endometrial carcinoma. Cancer Res 1993;53:5100-3.
5. Esteller M, Levine R, Baylin SB, Ellenson LH, Herman JG. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene 1998;17:2413-7.
6. Hampel H, Panescu J, Sotamaa K, Fix D, Frankel W, Comeras I, et al. Detection of hereditary nonpolyposis colorectal cancer (HNPCC) among newly diagnosed endometerial cancer patients. Cancer Res 2006;66:7810-7.
7. Simon R, Mirlacher M, Sauter G. Tissue microarray in cancer diagnosis. Expert Rev Mol Diagn 2003;3:421-30.
8. Basil JB, Goodfellow PJ, Rader JS, Mutch DJ, Herzog TJ. Clinical significance of microsatellite instability in endometrial carcinoma. Cancer 2000;89:1758-64.
9. Maxwell GL, Risinger JI, Alvarez AA, Barrett JC, Berchuck A. Favorable survival associated with microsatellite instability in endometrioid endometrial cancers. Obstet Gynecol 2001;97:417-22.
10. Tibiletti MG, Furlan D, Taborelli M, Facco C, Riva C, Franchi M, et al. Microsatellite instability in endometrial cancer: relation to histological subtypes. Gynecol Oncol 1999;73:247-52.
11. Baldinu P, Cossu A, Manca A, Salta MP, Pisamo M, Casula M, et al. Microsatellite instability and mutation analysis of candidate genes in unselected Sardinian patients with endometrial carcinoma. Cancer 2002;94:3157-68.
12. MacDonald ND, Salvesen HB, Ryan A, Iverson OE, Akslen LA, Jacobs IJ. Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomas. Cancer Res 2000;60:1750-2.
13. Caduff RF, Johnston CM, Svoboda-Newman SM, Poy EL, Merajver SD, Frank TS. Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma. Am J Pathol 1996;148:1671-8.
14. Fiumicino S, Ercoli A, Ferrandina G, Hess P, Raspaglio G, Rovella V, et al. Microsatellite instability is an independent indicator of recurrence in sporadic stage I-II endometrial adenocarcinoma. J Clin Oncol 2001;19:1008-14.
15. Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Noojin F, Conner W, et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995;56:29-33.
16. Boland CR, Thibodeau SN, Hamilton SR, Sirdransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
17. Kuismanen SA, Moisio AL, Schweizer P, Truninger K, Arola J, Jiricny J, et al. Endometrial and colorectal tumors from patients with hereditary nonpolyposis colon cancer display different patterns of microsatellite instability. Am J Pathol 2002;160:1953-8.
18. Ribic CM, Sargent DJ, Moore MJ, French AJ, Gryfe R, Tu D, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003;349:247-57.
19. Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 2005;23:609-18.
20. Duval A, Reperant M, Compoint A, Seruca R, Razani GN, Hamelin R, et al. Target gene mutation profile differs between gastrointestinal and endometrial tumors with mismatch repair deficiency. Cancer Res 2002;62:1609-12.
21. Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW, et al. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 1995;55:5548-50.
22. Gurin CC, Federici MG, Kang L, Boyd J. Causes and consequences of microsatellite instability in endometrial carcinoma. Cancer Res 1999;59:462-6.
23. Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004;92:744-51.